Product
ACTUS-101
1 clinical trial
1 indication
Indication
Pompe DiseaseClinical trial
A Phase 1 Study of the Safety of AAV2/8-LSPhGAA (ACTUS-101) in Late-onset Pompe DiseaseStatus: Active (not recruiting), Estimated PCD: 2022-09-30
1 clinical trial
1 indication